Company Filing History:
Years Active: 2014-2024
Title: The Innovative Contributions of Sergiy Yakovlev
Introduction
Sergiy Yakovlev is a notable inventor based in Rockville, MD (US). He has made significant contributions to the field of medical treatments, particularly in the area of inflammation and its associated mechanisms. With a total of 2 patents, his work has the potential to impact therapeutic approaches significantly.
Latest Patents
Yakovlev's latest patents include innovative methods and compositions aimed at treating inflammation. One of his patents focuses on "Compositions for inhibiting fibrin-VLDL receptor-dependent inflammation and methods of treatment." This invention provides a method of treating inflammation by administering a therapeutically effective amount of an agent that inhibits the binding of fibrin to the Very Low Density Lipoprotein Receptor (VLDLR). Additionally, it explores the combination of this agent with others that inhibit binding to VE-cadherin, enhancing the treatment's efficacy.
Another significant patent is titled "Compositions and methods utilizing fibrin beta chain fragments." This composition includes a peptide sequence corresponding to an amino acid sequence of a fibrin beta chain fragment. The invention details the structure of the peptide sequence, which may contain non-naturally occurring amino acid residues, and outlines methods for treatment that may include a polypeptide agent such as Thymosin beta 4.
Career Highlights
Sergiy Yakovlev is affiliated with the University System of Maryland, where he continues to engage in research and development. His work is characterized by a strong focus on innovative solutions to complex medical issues, particularly those related to inflammation.
Collaborations
Yakovlev has collaborated with notable colleagues, including Leonid Medved and Li Zhang. These partnerships have likely contributed to the advancement of his research and the successful development of his patents.
Conclusion
Sergiy Yakovlev's contributions to the field of medical treatments through his innovative patents demonstrate his commitment to addressing significant health challenges. His work continues to pave the way for new therapeutic approaches in the treatment of inflammation.